« Press Release: Emerson's PlantWeb® architecture to digitally automate new plant for first monoclonal antibody drugs in China | Main | Sharing, Drilling Down via XML and its Relatives »
March 31, 2008
Press Release: Emerson unveils new PAT tools to speed drug development and improve production
Cell growth model and process analytics accelerate product creation, rapid manufacturing scale-up and early real-time release of biological products
Austin, Texas (March 27, 2008) -- Emerson Process Management has expanded its software library with new PAT tools designed to speed development and improve production of life-saving drugs. Emerson's new high fidelity cell growth models and its multivariate process analytics accelerate product development, speed scale-up to full production, and enable real-time release of manufactured biological products.
Emerson's most recent work is the development models for mammalian cell processes that are currently in Beta testing. Cell growth models for bacterial, fungal, and yeast fermentations are available now. Previous studies indicate that the models can be used to prototype model predictive control of growth and product formulation rates which can in some cases reduce batch times by 40% and improve yields by 10%.
Biopharmaceutical product development is difficult and risky. Currently more than 200 biotechnology medicines are in development for more than 100 diseases. Due to process complexity, the products generally result only after lengthy iteration between process development and commercialization. Traditional development requires hundreds of trial batches, and then extensive data collection for final selection of processing conditions. Emerson's new PAT tools shorten the time and cost of development, and use real-time data to improve quality and yield of released final product.
The new tools use off-line dynamic computer simulations of bioprocesses that can be run at up to 1000X real time to determine optimum settings for real-time production. Also, for on-line operation, embedded analytics tools may be used to detect faults and predict end of batch values of quality parameters continuously in real time, helping to optimize batch process control and enable the efficiency of real-time release.
Emerson's new PAT tools for bioreactor modeling are in a library of software modules that run in its DeltaV™ digital automation system. The model, configuration, and tools are used to create a "virtual plant" that can simulate batch execution faster than by physical experimentation. PAT tools are also being developed as embedded software in the DeltaV system to support on-line analytics. The DeltaV system is commonly used in product development and is the process management system embedded in the Broadley-James bioreactor family.
The bioreactor models are available as a complete DeltaV solution designed specifically for the customer's product development application. Engineering and configuration services and training are included, supporting user needs for efficient operation and maintenance of the production simulation software.
Hi-Res Photo is available.
About Emerson Process Management
Emerson Process Management (www.emersonprocess.com), an Emerson business, is a leader in helping businesses automate their production, processing and distribution in the chemical, oil and gas, refining, pulp and paper, power, water and wastewater treatment, mining and metals, food and beverage, pharmaceutical and other industries. The company combines superior products and technology with industry-specific engineering, consulting, project management and maintenance services. Its brands include PlantWeb®, DeltaV™, Fisher®, Micro Motion®, Rosemount®, Mobrey®, Bristol®, Daniel®, Ovation®, and AMS® Suite.
About Emerson
Emerson (NYSE: EMR), based in St. Louis, is a global leader in bringing technology and engineering together to provide innovative solutions to customers through its network power, process management, industrial automation, climate technologies, and appliance and tools businesses. Sales in fiscal 2007 were $22.6 billion. For more information, visit www.Emerson.com.
Posted by Emerson's EasyDeltaV.com on March 31, 2008 | TrackBack (0)
TrackBacks
TrackBack URL for this entry:
http://news.easydeltav.com/mt/mt-tb.cgi/707
Listed below are links to weblogs that reference Press Release: Emerson unveils new PAT tools to speed drug development and improve production: